<DOC>
	<DOCNO>NCT00608153</DOCNO>
	<brief_summary>The CoCa study maximum daily dose 32 mg candesartan 16/12.5 mg candesartan/hydrochlorothiazide objective evaluate naturalistic condition , i.e . routine medical care condition , subject compliance well efficacy tolerability candesartan candesartan/HCT subject suffer essential hypertension .</brief_summary>
	<brief_title>Compliance Patients With Essential Hypertension Treated With Candesartan Candesartan/Hydrochlorothiazide</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Candesartan</mesh_term>
	<mesh_term>Candesartan cilexetil</mesh_term>
	<mesh_term>Hydrochlorothiazide</mesh_term>
	<criteria>essential hypertension candesartan treatment</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>essential hypertension</keyword>
	<keyword>ARB</keyword>
	<keyword>compliance</keyword>
	<keyword>candesartan</keyword>
</DOC>